Viewing Study NCT04093466


Ignite Creation Date: 2025-12-24 @ 4:13 PM
Ignite Modification Date: 2026-01-04 @ 6:57 AM
Study NCT ID: NCT04093466
Status: RECRUITING
Last Update Posted: 2024-10-17
First Post: 2019-09-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study of CX1003 (Kanitinib) in Patients with Advanced Solid Tumors
Sponsor: Beijing Konruns Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module